for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Ping An Healthcare and Technology Co Ltd

1833.HK

Latest Trade

92.60HKD

Change

1.70(+1.87%)

Volume

6,044,930

Today's Range

90.60

 - 

93.75

52 Week Range

51.00

 - 

135.00

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
90.90
Open
91.05
Volume
6,044,930
3M AVG Volume
129.61
Today's High
93.75
Today's Low
90.60
52 Week High
135.00
52 Week Low
51.00
Shares Out (MIL)
1,147.29
Market Cap (MIL)
104,289.00
Forward P/E
-142.01
Dividend (Yield %)
--

Next Event

Ping An Healthcare and Technology Co Ltd Annual Shareholders Meeting

Latest Developments

More

Ping An Healthcare And Technology Posts HY Loss Attributable RMB 213.6 MLN

Ping An Healthcare And Technology Says Ye Lan Appointed CFO

Ping An Healthcare And Technology Says To Remove Wang Tao As Chairman, Exec Director & CEO

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Ping An Healthcare and Technology Co Ltd

Ping An Healthcare and Technology Co Ltd is a company engaged in providing medical health products and services. The Company operates four segments. The Health Mall segment provides Chinese and western medicines (over-the-counter medicines), nutritional healthcare, medical equipment and other products. The Consumer Healthcare is involved in providing individual and corporate clients with a range of health services, including physical examination, medical beauty, oral and genetic testing. The Online Medical Services segment provides users with online consultation, referral, registration, online medication purchase and drug delivery services. The services are provided through its products which are Health 360 and Private Doctor Membership. The Health Management and Wellness Interaction segment provides advertising products and services for corporate clients.

Industry

Retail (Catalog & Mail Order)

Contact Info

Ugland House, Grand Cayman, KY1-1104

PO Box 309

SHANGHAI, SHA

China

http://www.pagd.net/

Executive Leadership

Tao Wang

Executive Chairman of the Board, Chief Executive Officer

Xue Bai

Chief Operating Officer

Qi Wang

Chief Technology Officer

Jian Qin

Legal representative and General Manager

Peng Wu

General Manager

Key Stats

1.72 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2018

3.3K

2019

5.1K

2020(E)

6.6K
EPS (CNY)

2018

-0.979

2019

-0.763

2020(E)

-0.543
Price To Earnings (TTM)
--
Price To Sales (TTM)
15.97
Price To Book (MRQ)
8.68
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
1.43
LT Debt To Equity (MRQ)
0.62
Return on Investment (TTM)
-7.01
Return on Equity (TTM)
-5.54

Latest News

Latest News

Breakingviews - Corona Capital: Donald Trump, Kenzo Takada

Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.

Exclusive: Baidu, investors in talks to raise $2 billion for biotech startup - source

Chinese tech giant Baidu <BIDU.O> is in talks with investors to raise up to $2 billion over three years for a biotech startup, which will use AI technology to discover new drugs and diagnose diseases, a person with direct knowledge of the matter said.

RPT-SoftBank's Son hopes 'winged unicorns' can save crumbling tech empire

SoftBank Group Corp CEO Masayoshi Son on Monday pinned his hopes on a small group of "winged unicorns" to save the performance of his $100 billion Vision Fund - although he gave few clues on which ones they would be.

SoftBank's Son hopes 'winged unicorns' can save crumbling tech empire

SoftBank Group Corp <9984.T> CEO Masayoshi Son on Monday pinned his hopes on a small group of "winged unicorns" to save the performance of his $100 billion Vision Fund - although he gave few clues on which ones they would be.

RPT-FOCUS-For SoftBank's Son, coronavirus turns vision to illusion

SoftBank Group Corp founder Masayoshi Son's dream of a global tech empire is unravelling, with the coronavirus crisis compounding losses at his $100 billion Vision Fund and distress at his big bets portending more pain.

For SoftBank's Son, coronavirus turns vision to illusion

SoftBank Group Corp <9984.T> founder Masayoshi Son's dream of a global tech empire is unravelling, with the coronavirus crisis compounding losses at his $100 billion Vision Fund and distress at his big bets portending more pain.

Breakingviews - Virus sets off China Inc’s biggest clash

China’s biggest corporate showdown has kicked off. Alibaba, Tencent and Ping An Insurance dominate e-commerce, video games and insurance respectively. Now the trio, worth a combined $1 trillion-plus in market capitalisation, is converging on healthcare.

Indonesia leans on healthtech startups to cope with virus surge

As coronavirus cases surge in Indonesia, doctors are working double-time treating patients both at hospitals and online through healthtech startups - an approach that is quickly becoming part of the national healthcare system.

Japan drugmaker Shionogi to tie up with Ping An as eyes China expansion

Japan's Shionogi & Co <4507.T>, creator of the blockbuster cholesterol treatment Crestor, said on Monday it would tie up with Ping An Insurance Group Co of China <601318.SS>, selling a 2.05% voting stake for 33.53 billion yen ($311 million).

Coronavirus spurs Ping An Good Doctor to hire hundreds of doctors in Indonesia

China's Ping An Good Doctor said its healthcare venture with ride hailing firm Grab plans to hire hundreds of doctors in Indonesia after the spread of the coronavirus caused demand for online consultations in the country to almost double.

Exclusive: Tencent-backed WeDoctor invites banks to lead $1 billion Hong Kong IPO, sources say

WeDoctor will push ahead with a Hong Kong listing and invite pitches from investments banks next week to lead an IPO valuing the Chinese healthcare platform at up to $10 billion, two sources with direct knowledge of the matter said.

Worried Chinese turn to online doctor consultations amid coronavirus outbreak

Spooked by a sneeze or a cough, Chinese consumers are turning to online consultations in droves for advice about possible coronavirus symptoms - a boon for a fledgling industry that has struggled to win over customers.

SoftBank’s China strategy wobbles as key bets disappoint

For SoftBank Group Corp <9984.T>, financial technology firm OneConnect's IPO should have been a vindication of an aggressive China investing strategy.

Factbox: Snakes and ladders- SoftBank Vision Fund's climbing, sliding valuations

The $100 billion Vision Fund of Japan's SoftBank Group Corp <9984.T> has in just over two years burnt through much of its capital investing in money-losing, late-stage tech startups in areas as varied as autonomous driving, healthcare and finance.

Ping An's OneConnect picks banks for up to $1 billion Hong Kong IPO: sources

Ping An Insurance's OneConnect financial technology unit has selected Goldman Sachs, JPMorgan and Morgan Stanley to work on its Hong Kong initial public offering (IPO) of up to $1 billion, people with direct knowledge of the matter said.

SoftBank's Vision Fund to hire China team, set up mainland office: sources

The SoftBank-led Vision Fund is hiring an investment team to be based in China as the $100 billion investment giant expands in one of the world's most vibrant tech markets, two people with direct knowledge of the move told Reuters.

Softbank pushes link-ups as insurance strategy takes shape

Softbank's Vision Fund plans to pump more money into insurance, a sector it sees as both ripe for disruption and a potential booster for its bigger bets in cars, health and financial services, a Vision Fund executive told Reuters.

UPDATE 1-Trading, IPO surge bumps HKEX first-half net to record high

* H1 net profit HK5.04 billion vs HK$3.49 billion year earlier

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up